Back to the Virtual Exhibit Hall


Intended for US Audiences Only

Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.



Wendy King


Jim Napoleon


PDF icon aHUS and Infections.pdf

PDF icon Guidelines Resource.pdf

PDF icon PNH Testing Leave Behind.pdf

PDF icon PNH Diagnostic Reference Tool.pdf